✦ LIBER ✦

The Future is Now: Advances With Vaccines for the Prevention of Cervical Cancer and Other HPV-Related Diseases

Book ID: 113960777
Publisher: Elsevier Science
Year: 2006
Tongue: English
Weight: 81 KB
Volume: 102
Category: Article
ISSN: 0090-8258
DOI: 10.1016/j.ygyno.2006.08.002

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Distribution of HPV types associated wit

Distribution of HPV types associated with cervical cancers in Scotland and implications for the impact of HPV vaccines

✍ Cuschieri, K; Brewster, D H; Williams, A R W; Millan, D; Murray, G; Nicoll, S; I 📂 Article 📅 2010 🏛 Nature Publishing Group 🌐 English ⚖ 148 KB

A prophylactic quadrivalent vaccine for

A prophylactic quadrivalent vaccine for the prevention of infection and disease related to HPV-6, -11, -16 and -18

✍ Goldstone, Stephen E; Vuocolo, Scott 📂 Article 📅 2012 🏛 Expert Reviews 🌐 English ⚖ 849 KB

Benefits, cost requirements and cost-eff

Benefits, cost requirements and cost-effectiveness of the HPV16,18 vaccine for cervical cancer prevention in developing countries: policy implications

✍ Sue J Goldie; Meredith O'Shea; Mireia Diaz; Sun-Young Kim 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 603 KB

High load for most high risk human papil

High load for most high risk human papillomavirus genotypes is associated with prevalent cervical cancer precursors but only HPV16 load predicts the development of incident disease

✍ Patti E. Gravitt; Melinda Butsch Kovacic; Rolando Herrero; Mark Schiffman; Conce 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 French ⚖ 168 KB 👁 2 views

## Abstract Cervicovaginal human papillomavirus (HPV) viral load has been purported as a potential marker for the detection of high‐grade cervical intraepithelial neoplasia or cancer (≥CIN2). To examine disease association with type‐specific viral load for the full‐range of anogenital HPV infection

PCN1O: COMPARISON OF COSTS AND EFFECTS O

PCN1O: COMPARISON OF COSTS AND EFFECTS OF PROPHYLACTIC CLODRONATE FOR THE PREVENTION OF SKELETAL RELATED EVENTS IN PATIENTS WITH ADVANCED BREAST CANCER IN POLAND

✍ E Orlewska 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 56 KB

PCN3: COMPARISON OF COSTS AND EFFECTS OF

PCN3: COMPARISON OF COSTS AND EFFECTS OF PROPHYLACTIC PAMIDRONATE FOR THE PREVENTION OF SKELETAL RELATED EVENTS IN PATIENTS WITH ADVANCED BREAST CANCER IN POLAND (COST-EFFECTIVENESS AND COST-UTILITY ANALYSIS)

✍ E Orlewska 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 58 KB